[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Prostate Cancer Medicine Market Report 2017

November 2017 | 104 pages | ID: A8F30788F32EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Prostate Cancer Medicine for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Prostate Cancer Medicine market competition by top manufacturers/players, with Prostate Cancer Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca plc
  • Active Biotech
  • Bristol Myers-Squibb
  • Teva Pharmaceuticals Industries Ltd.
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Roche Holding AG
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Hormonal Therapy Drugs
  • Chemotherapy Drugs
  • Immunotherapy Drugs
  • Target Therapy Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Prostate Cancer Medicine for each application, includin
  • Hospital
  • Pharmacy
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Prostate Cancer Medicine Market Report 2017

1 PROSTATE CANCER MEDICINE OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Medicine
1.2 Classification of Prostate Cancer Medicine by Product Category
  1.2.1 Asia-Pacific Prostate Cancer Medicine Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Prostate Cancer Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Hormonal Therapy Drugs
  1.2.4 Chemotherapy Drugs
  1.2.5 Immunotherapy Drugs
  1.2.6 Target Therapy Drugs
1.3 Asia-Pacific Prostate Cancer Medicine Market by Application/End Users
  1.3.1 Asia-Pacific Prostate Cancer Medicine Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Others
1.4 Asia-Pacific Prostate Cancer Medicine Market by Region
  1.4.1 Asia-Pacific Prostate Cancer Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Prostate Cancer Medicine (2012-2022)
  1.5.1 Asia-Pacific Prostate Cancer Medicine Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PROSTATE CANCER MEDICINE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Prostate Cancer Medicine Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Prostate Cancer Medicine Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Prostate Cancer Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Prostate Cancer Medicine (Volume and Value) by Type
  2.2.1 Asia-Pacific Prostate Cancer Medicine Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Prostate Cancer Medicine Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Prostate Cancer Medicine (Volume) by Application
2.4 Asia-Pacific Prostate Cancer Medicine (Volume and Value) by Region
  2.4.1 Asia-Pacific Prostate Cancer Medicine Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Prostate Cancer Medicine Revenue and Market Share by Region (2012-2017)

3 CHINA PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

3.1 China Prostate Cancer Medicine Sales and Value (2012-2017)
  3.1.1 China Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  3.1.3 China Prostate Cancer Medicine Sales Price Trend (2012-2017)
3.2 China Prostate Cancer Medicine Sales Volume and Market Share by Type
3.3 China Prostate Cancer Medicine Sales Volume and Market Share by Application

4 JAPAN PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Prostate Cancer Medicine Sales and Value (2012-2017)
  4.1.1 Japan Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Prostate Cancer Medicine Sales Price Trend (2012-2017)
4.2 Japan Prostate Cancer Medicine Sales Volume and Market Share by Type
4.3 Japan Prostate Cancer Medicine Sales Volume and Market Share by Application

5 SOUTH KOREA PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Prostate Cancer Medicine Sales and Value (2012-2017)
  5.1.1 South Korea Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Prostate Cancer Medicine Sales Price Trend (2012-2017)
5.2 South Korea Prostate Cancer Medicine Sales Volume and Market Share by Type
5.3 South Korea Prostate Cancer Medicine Sales Volume and Market Share by Application

6 TAIWAN PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Prostate Cancer Medicine Sales and Value (2012-2017)
  6.1.1 Taiwan Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Prostate Cancer Medicine Sales Price Trend (2012-2017)
6.2 Taiwan Prostate Cancer Medicine Sales Volume and Market Share by Type
6.3 Taiwan Prostate Cancer Medicine Sales Volume and Market Share by Application

7 INDIA PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

7.1 India Prostate Cancer Medicine Sales and Value (2012-2017)
  7.1.1 India Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  7.1.3 India Prostate Cancer Medicine Sales Price Trend (2012-2017)
7.2 India Prostate Cancer Medicine Sales Volume and Market Share by Type
7.3 India Prostate Cancer Medicine Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Prostate Cancer Medicine Sales and Value (2012-2017)
  8.1.1 Southeast Asia Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Prostate Cancer Medicine Sales Price Trend (2012-2017)
8.2 Southeast Asia Prostate Cancer Medicine Sales Volume and Market Share by Type
8.3 Southeast Asia Prostate Cancer Medicine Sales Volume and Market Share by Application

9 AUSTRALIA PROSTATE CANCER MEDICINE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Prostate Cancer Medicine Sales and Value (2012-2017)
  9.1.1 Australia Prostate Cancer Medicine Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Prostate Cancer Medicine Sales Price Trend (2012-2017)
9.2 Australia Prostate Cancer Medicine Sales Volume and Market Share by Type
9.3 Australia Prostate Cancer Medicine Sales Volume and Market Share by Application

10 ASIA-PACIFIC PROSTATE CANCER MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AstraZeneca plc
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AstraZeneca plc Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Active Biotech
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Active Biotech Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Bristol Myers-Squibb
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Teva Pharmaceuticals Industries Ltd.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Johnson & Johnson
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Johnson & Johnson Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Pfizer Inc.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Pfizer Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Bayer AG
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Bayer AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Abbott Laboratories
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Abbott Laboratories Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Astellas Pharma Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Roche Holding AG
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Prostate Cancer Medicine Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Roche Holding AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 PROSTATE CANCER MEDICINE MANUFACTURING COST ANALYSIS

11.1 Prostate Cancer Medicine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Prostate Cancer Medicine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Prostate Cancer Medicine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PROSTATE CANCER MEDICINE MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Prostate Cancer Medicine Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Prostate Cancer Medicine Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Prostate Cancer Medicine Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Prostate Cancer Medicine Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Prostate Cancer Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Prostate Cancer Medicine Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Prostate Cancer Medicine Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Prostate Cancer Medicine Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Prostate Cancer Medicine Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Prostate Cancer Medicine Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer Medicine
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Hormonal Therapy Drugs Product Picture
Figure Chemotherapy Drugs Product Picture
Figure Immunotherapy Drugs Product Picture
Figure Target Therapy Drugs Product Picture
Figure Asia-Pacific Prostate Cancer Medicine Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Prostate Cancer Medicine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Prostate Cancer Medicine Market Size (Million USD) by Region (2012-2022)
Figure China Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Prostate Cancer Medicine Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Prostate Cancer Medicine Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Prostate Cancer Medicine Sales Share by Players/Suppliers
Figure Asia-Pacific Prostate Cancer Medicine Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Prostate Cancer Medicine Revenue Share by Players
Figure 2017 Asia-Pacific Prostate Cancer Medicine Revenue Share by Players
Table Asia-Pacific Prostate Cancer Medicine Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostate Cancer Medicine by Type (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Medicine by Type (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Prostate Cancer Medicine by Region (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Sales Market Share by Region in 2016
Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Prostate Cancer Medicine by Region (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Region in 2016
Table Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Prostate Cancer Medicine Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Prostate Cancer Medicine Sales Market Share by Application (2012-2017)
Figure China Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure China Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table China Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table China Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure China Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table China Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table China Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure China Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure Japan Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table Japan Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure Japan Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table Japan Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Japan Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure Japan Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure South Korea Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table South Korea Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure South Korea Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table South Korea Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure South Korea Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure Taiwan Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table Taiwan Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure India Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure India Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table India Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table India Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure India Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table India Prostate Cancer Medicine Sales Volume (K Units) by Application (2012-2017)
Table India Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure India Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table Southeast Asia Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Figure Australia Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Prostate Cancer Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Prostate Cancer Medicine Sales Volume (K Units) by Type (2012-2017)
Table Australia Prostate Cancer Medicine Sales Volume Market Share by Type (2012-2017)
Figure Australia Prostate Cancer Medicine Sales Volume Market Share by Type in 2016
Table Australia Prostate Cancer Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Australia Prostate Cancer Medicine Sales Volume Market Share by Application (2012-2017)
Figure Australia Prostate Cancer Medicine Sales Volume Market Share by Application in 2016
Table AstraZeneca plc Prostate Cancer Medicine Basic Information List
Table AstraZeneca plc Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Active Biotech Prostate Cancer Medicine Basic Information List
Table Active Biotech Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol Myers-Squibb Prostate Cancer Medicine Basic Information List
Table Bristol Myers-Squibb Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Basic Information List
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Prostate Cancer Medicine Basic Information List
Table Johnson & Johnson Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc. Prostate Cancer Medicine Basic Information List
Table Pfizer Inc. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer AG Prostate Cancer Medicine Basic Information List
Table Bayer AG Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories Prostate Cancer Medicine Basic Information List
Table Abbott Laboratories Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Pharma Inc. Prostate Cancer Medicine Basic Information List
Table Astellas Pharma Inc. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Holding AG Prostate Cancer Medicine Basic Information List
Table Roche Holding AG Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Medicine
Figure Manufacturing Process Analysis of Prostate Cancer Medicine
Figure Prostate Cancer Medicine Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Medicine
Table Distributors/Traders List
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Prostate Cancer Medicine Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share Forecast by Region in 2022
Figure China Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Prostate Cancer Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Prostate Cancer Medicine Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Medicine Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Prostate Cancer Medicine Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Prostate Cancer Medicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories